Trium Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Trium Capital’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-245,597	Closed	-$9.66M	–	101
2023 Q2	$9.66M	Buy	+245,597	New	+$8.67M	2.06%	6

Trium Capital's ISEE Position: Q3 2023 in Review

Trium Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 245,597 shares — an estimated $9.66M sold.

Trium Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $9.66M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Trium Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Trium Capital sold 245,597 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $9.66M.
Trium Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Trium Capital's IVERIC bio, Inc. Common Stock position peaked at $9.66M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Trium Capital's 13F filing for Q3 2023, filed 6 Nov 2023.